FESTEL CAPITAL

R&D spin offs with the appropriate investment strategy can make an important contribution to the flexibilisation of a company's internal R&D and therefore increase productivity.

In addition to various projects executed, FESTEL CAPITAL has also investigated the trends and success factors of R&D spin-offs in the chemical, pharmaceutical and biotech industry.

More information regarding buyouts in the chemical industry (in German) can be found at

www.chemie-buyout.com

                    Disclaimer               Privacy Policy                   Terms of Use                   Site Map                   Imprint             

 © FESTEL CAPITAL